Test Price
2,800 AED✅ Home Collection Available
Paternal UPD Chromosome 14 (Kagami-Ogata Syndrome) Genetic Test in UAE | 2,800 AED | DHA Licensed
Executive Summary & Core Metrics
Executive Summary: Definitive molecular diagnosis with 99.9% diagnostic sensitivity via ISO‑accredited processing, hospital‑grade cold‑chain home collection, complimentary telephonic post‑test genetic counselling, and direct insurance verification via WhatsApp.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO‑accredited processing and orthogonal NGS‑RNA confirmation.
- Premium Logistics: Paid hospital‑grade home collection with ISO‑certified cold‑chain transport; VIP mobile phlebotomy available 8 AM – 11 PM.
- Clinical Guidance: Complimentary telephonic post‑test result interpretation by a DHA‑licensed Consultant Medical Geneticist.
- Insurance: Direct billing verification – send your Emirates ID & policy details via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This Next‑Generation Sequencing assay detects paternal uniparental disomy of chromosome 14, providing a definitive molecular diagnosis for Kagami‑Ogata syndrome with 99.9% clinical sensitivity. It integrates transcriptome RNA sequencing for functional validation, making it the most advanced molecular test for pediatric dysmorphology in the UAE. The methodology encompasses targeted NGS panel sequencing, orthogonal RNA‑seq confirmation, and bioinformatic analysis using population‑specific reference databases to ensure accurate UPD detection.
| Feature | Our NGS UPD Test | Chromosomal Microarray |
|---|---|---|
| Diagnostic Precision | Targeted detection of paternal UPD 14 with 99.9% sensitivity/specificity | Cannot distinguish UPD without parental DNA; often misses UPD |
| Methodology | NGS + Transcriptome RNA Sequencing | SNP‑array or CGH‑array |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
Physician Insight & Safety Protocols
“As a Consultant Medical Geneticist, I recognize the deep concern families experience when a rare syndrome is suspected. This NGS assay delivers a definitive molecular answer for paternal UPD of chromosome 14, yet it must always be interpreted within the full clinical context of the child. No treatment decisions should be made solely on the basis of this result without a comprehensive discussion with the managing clinical team.” – Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Exclusion Criteria & Emergency Red Flags
- Exclusion: Individuals unable to provide informed consent; minors without legal guardian authorization in accordance with UAE Federal Law No. 2 of 2019 concerning health information technology.
- Exclusion: Recent allogeneic hematopoietic stem cell transplant (within 3 months) – may cause mixed DNA profiles that interfere with UPD detection.
- ER Red Flag: Seek immediate medical care if the child develops acute respiratory distress, refractory seizures, or severe feeding intolerance. These symptoms require urgent clinical intervention independent of genetic testing.
Patient FAQ & Clinical Guidance
1. What is the purpose of this test?
This NGS assay identifies paternal uniparental disomy of chromosome 14, confirming Kagami‑Ogata syndrome in neonates and children presenting with characteristic dysmorphic features, abdominal wall defects, and developmental delays. It provides clinicians with a molecular‑level diagnosis that guides feeding support, respiratory monitoring, and developmental intervention strategies.
2. How is the sample collected?
A trained home phlebotomist collects a small whole blood sample via finger prick onto an FTA card or by standard venipuncture. No fasting is required. Samples are transported under ISO‑certified cold‑chain conditions within 2 hours to our central laboratory. VIP mobile phlebotomy is available daily from 8 AM to 11 PM.
3. When will I receive the results?
Results are reported within 3 to 4 weeks and include a detailed clinical interpretation with variant classification. A DHA‑licensed genetic counsellor will contact you to schedule a complimentary tele‑consultation to explain the findings and discuss next steps.
4. Is genetic counselling provided with this test?
Yes, pre‑test and post‑test genetic counselling is included. Our team of certified genetic counsellors and the Consultant Medical Geneticist are available to discuss the implications of the results for the child and family members.
UAE Regulatory & Data Privacy Adherence
Data Protection & Health Information Governance: This service operates in full compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic sequence data are encrypted and stored exclusively on UAE‑based servers with restricted access controls. Clinical safety and patient consent procedures adhere to Federal Decree‑Law No. 4 of 2016 on Medical Liability. Our laboratory holds ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | Paternal UPD Chromosome 14 (Kagami-Ogata Syndrome) Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood (FTA Card or Venipuncture) |
| Methodology Used | Next‑Generation Sequencing (NGS) + Transcriptome RNA Sequencing |
| ICD-10-CM Code | Q99.8, Q87.19, Z13.79 |
| LOINC Code | 94493-2 |
| DHA Facility License & Laboratory Address | DHA Facility License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians